李嘉诚家族 卖药净赚30亿

21世纪经济报道
Mar 08

李嘉诚,卖药大赚一笔。  3月5日晚,旗下和黄医药公布,2025年营收约合38亿元人民币,净利超过30亿元,同比暴增11倍。净利激增,得益于一笔股权交易的一次性收益。  论资产组合,和黄医药在李家的分量有限。  其市值约170亿元人民币,李嘉诚控制的长和,持有约四成股权,价值仅70亿元。  和黄医药管理层称,旗下抗体靶向偶联药物平台(ATTC),已有两款产品进入全球开发阶段,正积极寻找伙伴,推进...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10